Epidemiology of diabetes - Status of a pandemic and issues around metabolic surgery

Diabetes Care

Volumn 39, Issue 6, 2016, Pages 878-883

  Zimmet, Paul Z ^a   Alberti, K George M M ^b  

^a MONASH UNIVERSITY   (Australia)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA DERIVATIVE;

ASIAN; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CONFERENCE PAPER; EPIDEMIC; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PATIENT SELECTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CHILD; DEVELOPING COUNTRY; DIABETES MELLITUS, TYPE 2; FEMALE; LIFESTYLE; MALE; MIDDLE AGED; PANDEMIC; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BARIATRIC SURGERY; CHILD; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PANDEMICS; RISK FACTORS; YOUNG ADULT;

EID: 84971322227     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0273     Document Type: Conference Paper

References (46)

1. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014;2:56-64
2. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 2014; 383:1084-1094
3. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitusd present and future perspectives. Nat Rev Endocrinol 2011;8:228-236
4. Zimmet P, Alberti KGMM. Surgery or medical therapy for obese patients with type 2 diabetes? N Engl J Med 2012;366:1635-1636
5. American Diabetes Association. Standards of medical care in diabetesd2015. Diabetes Care 2015;38(Suppl. 1):S1-S93
6. Zimmet P, Alberti KGMM, Rubino F, Dixon JB. IDF's view of bariatric surgery in type 2 diabetes. Lancet 2011;378:108-110
7. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med 2011;28:628-642
8. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-1585
9. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576
10. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140-149
11. Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care 2016;39:472-485
12. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971;2:125-128
13. Zimmet P, Taft P, Guinea A, Guthrie W, Thoma K. The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia 1977;13:111-115
14. Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDMdlessons from the South Pacific. Diabetes Metab Rev 1990;6:91-124
15. Prior IA, Davidson F. The epidemiology of diabetes in Polynesians and Europeans in New Zealand and the Pacific. N Z Med J 1966;65:375-383
16. Colagiuri S, Colagiuri R, Na'ati S, Muimuiheata S, HussainZ,PaluT.The prevalence of diabetes in the kingdom of Tonga. Diabetes Care 2002; 25:1378-1383
17. International Diabetes Federation. Diabetes Atlas. 1st ed. Brussels, Belgium, International Diabetes Federation. 2000
18. International Diabetes Federation. Diabetes Atlas. 7th ed. Brussels, Belgium, International Diabetes Federation, 2015
19. Xu Y, Wang L, He J, et al.; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-959
20. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008;31:893-898
21. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
22. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
23. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-321
24. Shanghai Diabetes Research Cooperative Group. Diabetes mellitus survey in Shanghai. Chin Med J (Engl) 1980;93:663-672
25. Ning F, Pang ZC, Dong YH, et al.; Qingdao Diabetes Survey Group. Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China. Diabet Med 2009;26:855-863
26. Anjana RM, Shanthi Rani CS, Deepa M, et al. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448
27. Magliano DJ, Söderberg S, Zimmet PZ, et al. Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 2012;35:87-91
28. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
29. Satman I, Omer B, Tutuncu Y, et al.; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-180
30. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007;369:750-756
31. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA 2015;314:1021-1029
32. Khambalia A, Phongsavan P, Smith BJ, et al. Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health 2011;11:719
33. Franco M, Bilal U, Orduñez P, et al. Populationwide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ 2013;346:f1515
34. Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care 2015;38:482-487
35. Robinson MK. Surgical treatment of obesity- weighing the facts. N Engl J Med 2009;361:520-521
36. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007;86:353-359
37. WHO Expert Consultation. Appropriate body mass index for Asian populations and its complications for policy and intervention strategies. Lancet 2004;363:157-163
38. Whincup PH, Nightingale CM, Owen CG, et al. Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Med 2010;7:e1000263
39. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73
40. Gluckman PD, Hanson M, Zimmet P, Forrester T. Losing the war against obesity: the need for a developmental perspective. Sci Transl Med 2011;3:93cm19
41. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998;351:173-177
42. Li Y, He Y, Qi L, et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes 2010;59:2400-2406
43. Pan XR, Li GW, Hu YH, et al.Effectsofdietand exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
44. Lindström J, Ilanne-Parikka P, Peltonen M, et al.; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679
45. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
46. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012;367:695-704